Seizure susceptibility in immature brain due to lack of COX-2-induced PGF2α

Experimental Neurology

Volumn 249, Issue , 2013, Pages 95-103

  Chung, Jee In ^a   Kim, A Young ^a   Lee, Soo Hwan ^a   Baik, Eun Joo ^a  

^a Ajou University School of Medicine   (South Korea)

Author keywords

Cyclooxygenase; Developing brain; Prostaglandin F2 ; Seizure

Indexed keywords

ANTICONVULSIVE AGENT; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; IBUPROFEN; INDOMETACIN; KAINIC ACID; KETOPROFEN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR;

ADULT ANIMAL; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN DEVELOPMENT; DEGLYCOSYLATION; DRUG POTENCY; ENZYME ACTIVITY; FEBRILE CONVULSION; GLYCOSYLATION; HIPPOCAMPAL CA3 REGION; IN VITRO STUDY; IN VIVO STUDY; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEIZURE; SEIZURE SUSCEPTIBILITY; TONIC CLONIC SEIZURE;

CYCLOOXYGENASE; DEVELOPING BRAIN; PROSTAGLANDIN F(2Α); SEIZURE;

AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; BRAIN; CELLS, CULTURED; CYCLOOXYGENASE 2; DINOPROST; DISEASE SUSCEPTIBILITY; GLYCOSYLATION; MICE; SEIZURES; UP-REGULATION;

EID: 84884379540     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2013.08.014     Document Type: Article

References (37)

1. Albala B.J., Moshe S.L., Okada R. Kainic-acid-induced seizures: a developmental study. Brain Res. 1984, 315:139-148.
2. - cotransporter, in epilepsy-associated malformations of cortical development. Neuroscience 2007, 145:185-196.
3. Baik E.J., Kim E.J., Lee S.H., Moon C. Cyclooxygenase-2 selective inhibitors aggravate kainic acid induced seizure and neuronal cell death in the hippocampus. Brain Res. 1999, 843:118-129.
4. Caracciolo L., Barbon A., Palumbo S., Mora C., Toscano C.D., Bosetti F., et al. Altered mRNA editing and expression of ionotropic glutamate receptors after kainic acid exposure in cyclooxygenase-2 deficient mice. PLoS One 2011, 6:e19398.
5. Claycomb R.J., Hewett S.J., Hewett J.A. Neuromodulatory role of endogenous interleukin-1beta in acute seizures: possible contribution of cyclooxygenase-2. Neurobiol. Dis. 2012, 45:234-242.
6. DeLorenzo R.J., Towne A.R., Pellock J.M., Ko D. Status epilepticus in children, adults, and the elderly. Epilepsia 1992, 33(Suppl. 4):S15-S25.
7. Habib A., Creminon C., Frobert Y., Grassi J., Pradelles P., Maclouf J. Demonstration of an inducible cyclooxygenase in human endothelial cells using antibodies raised against the carboxyl-terminal region of the cyclooxygenase-2. J. Biol. Chem. 1993, 268:23448-23454.
8. Hickey R.W., Adelson P.D., Johnnides M.J., Davis D.S., Yu Z., Rose M.E., et al. Cyclooxygenase-2 activity following traumatic brain injury in the developing rat. Pediatr. Res. 2007, 62:271-276.
9. Holmes G.L. Epilepsy in the developing brain: lessons from the laboratory and clinic. Epilepsia 1997, 38:12-30.
10. Holmes G.L., Milh M.D., Dulac O. Maturation of the human brain and epilepsy. Handb. Clin. Neurol. 2012, 107:135-143.
11. Holtman L., van Vliet E.A., Edelbroek P.M., Aronica E., Gorter J.A. Cox-2 inhibition can lead to adverse effects in a rat model for temporal lobe epilepsy. Epilepsy Res. 2010, 91:49-56.
12. Jang B.C., Sung S.H., Park J.G., Park J.W., Bae J.H., Shin D.H., et al. Glucosamine hydrochloride specifically inhibits COX-2 by preventing COX-2 N-glycosylation and by increasing COX-2 protein turnover in a proteasome-dependent manner. J. Biol. Chem. 2007, 282:27622-27632.
13. Jarvela J.T., Lopez-Picon F.R., Holopainen I.E. Age-dependent cyclooxygenase-2 induction and neuronal damage after status epilepticus in the postnatal rat hippocampus. Epilepsia 2008, 49:832-841.
14. Jung K.H., Chu K., Lee S.T., Kim J., Sinn D.I., Kim J.M., et al. Cyclooxygenase-2 inhibitor, celecoxib, inhibits the altered hippocampal neurogenesis with attenuation of spontaneous recurrent seizures following pilocarpine-induced status epilepticus. Neurobiol. Dis. 2006, 23:237-246.
15. Kidd F.L., Isaac J.T. Developmental and activity-dependent regulation of kainate receptors at thalamocortical synapses. Nature 1999, 400:569-573.
16. Kim H.J., Chung J.I., Lee S.H., Jung Y.S., Moon C.H., Baik E.J. Involvement of endogenous prostaglandin F2alpha on kainic acid-induced seizure activity through FP receptor: the mechanism of proconvulsant effects of COX-2 inhibitors. Brain Res. 2008, 1193:153-161.
17. Knoebel E.E. Fever: to treat or not to treat. Point. Clin. Pediatr. (Phila) 2002, 41:9-11.
18. Kukko-Lukjanov T.K., Lintunen M., Jalava N., Lauren H.B., Lopez-Picon F.R., Michelsen K.A., et al. Involvement of histamine 1 receptor in seizure susceptibility and neuroprotection in immature mice. Epilepsy Res. 2010, 90:8-15.
19. Litalien C., Jacqz-Aigrain E. Risks and benefits of nonsteroidal anti-inflammatory drugs in children: a comparison with paracetamol. Paediatr. Drugs 2001, 3:817-858.
20. Morrison R.S., Wenzel H.J., Kinoshita Y., Robbins C.A., Donehower L.A., Schwartzkroin P.A. Loss of the p53 tumor suppressor gene protects neurons from kainate-induced cell death. J. Neurosci. 1996, 16:1337-1345.
21. Ostergaard J.R. Febrile seizures. Acta Paediatr. 2009, 98:771-773.
22. Otto J.C., Smith W.L. The orientation of prostaglandin endoperoxide synthases-1 and -2 in the endoplasmic reticulum. J. Biol. Chem. 1994, 269:19868-19875.
23. Otto J.C., DeWitt D.L., Smith W.L. N-glycosylation of prostaglandin endoperoxide synthases-1 and -2 and their orientations in the endoplasmic reticulum. J. Biol. Chem. 1993, 268:18234-18242.
24. Polascheck N., Bankstahl M., Loscher W. The COX-2 inhibitor parecoxib is neuroprotective but not antiepileptogenic in the pilocarpine model of temporal lobe epilepsy. Exp. Neurol. 2010, 224:219-233.
25. Rakhade S.N., Jensen F.E. Epileptogenesis in the immature brain: emerging mechanisms. Nat. Rev. Neurol. 2009, 5:380-391.
26. Rantala H., Tarkka R., Uhari M. Preventive treatment for recurrent febrile seizures. Ann. Med. 2000, 32:177-180.
27. Regnier A., Vicaut E., Mraovitch S. Aggravation of seizure-associated microvascular injuries by ibuprofen may involve multiple pathways. Epilepsia 2010, 51:2412-2422.
28. Salvadori M.G., Bandero C.R., Jesse A.C., Gomes A.T., Rambo L.M., Bueno L.M., et al. Prostaglandin E(2) potentiates methylmalonate-induced seizures. Epilepsia 2012, 53:189-198.
29. Serrano G.E., Lelutiu N., Rojas A., Cochi S., Shaw R., Makinson C.D., et al. Ablation of cyclooxygenase-2 in forebrain neurons is neuroprotective and dampens brain inflammation after status epilepticus. J. Neurosci. 2011, 31:14850-14860.
30. Sperber E.F., Veliskova J., Germano I.M., Friedman L.K., Moshe S.L. Age-dependent vulnerability to seizures. Adv. Neurol. 1999, 79:161-169.
31. Sperk G., Lassmann H., Baran H., Seitelberger F., Hornykiewicz O. Kainic acid-induced seizures: dose-relationship of behavioural, neurochemical and histopathological changes. Brain Res. 1985, 338:289-295.
32. Stempak D., Gammon J., Klein J., Koren G., Baruchel S. Single-dose and steady-state pharmacokinetics of celecoxib in children. Clin. Pharmacol. Ther. 2002, 72:490-497.
33. Strengell T., Uhari M., Tarkka R., Uusimaa J., Alen R., Lautala P., et al. Antipyretic agents for preventing recurrences of febrile seizures: randomized controlled trial. Arch. Pediatr. Adolesc. Med. 2009, 163:799-804.
34. Takei S., Hasegawa-Ishii S., Uekawa A., Chiba Y., Umegaki H., Hosokawa M., et al. Immunohistochemical demonstration of increased prostaglandin F(2)alpha levels in the rat hippocampus following kainic acid-induced seizures. Neuroscience 2012, 218:295-304.
35. Tocco G., Freire-Moar J., Schreiber S.S., Sakhi S.H., Aisen P.S., Pasinetti G.M. Maturational regulation and regional induction of cyclooxygenase-2 in rat brain: implications for Alzheimer's disease. Exp. Neurol. 1997, 144:339-349.
36. Toscano C.D., Ueda Y., Tomita Y.A., Vicini S., Bosetti F. Altered GABAergic neurotransmission is associated with increased kainate-induced seizure in prostaglandin-endoperoxide synthase-2 deficient mice. Brain Res. Bull. 2008, 75:598-609.
37. Yoshikawa K., Kita Y., Kishimoto K., Shimizu T. Profiling of eicosanoid production in the rat hippocampus during kainic acid-induced seizure: dual phase regulation and differential involvement of COX-1 and COX-2. J. Biol. Chem. 2006, 281:14663-14669.